3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
74
Phase 2
40
Phase 1/2
38
Phase 3
28
Phase NA
25
Phase 2/3
6
Phase EARLY_PHASE1
4
Phase 4
2
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
36
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Neoplasms
66
Breast Neoplasms
64
Prostatic Neoplasms
46
Carcinoma, Non-Small-Cell Lung
40
Neoplasm Metastasis
23
Colorectal Neoplasms
21
Multiple Myeloma
20
Pain
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Anemia
16
Keratosis, Actinic
15
Lung Neoplasms
14
Cancer Pain
14
Lymphoma, Non-Hodgkin
12
Lymphoma, Follicular
11
Leukemia
11
Leukemia, Lymphocytic, Chronic, B-Cell
10
Carcinoma, Renal Cell
10
Carcinoma, Hepatocellular
9
Carcinoma
9
Neuroendocrine Tumors
8
Melanoma
8
Lymphoma
8
Ovarian Neoplasms
7
Leukemia, Myeloid, Acute
7
Uterine Cervical Neoplasms
6
Recurrence
6
Gastrointestinal Stromal Tumors
6
Stomatitis
5
Stomach Neoplasms
5
Interventions
Technetium Tc 99m Aggregated Albumin
1
Radionuclide Generators
1
Radiofrequency Ablation
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
INDUSTRY
×
Liver Neoplasms
×
Clear all
NCT05848947
2025-01-29
MAApping
Sirtex Medical
Phase 4
Completed
5 enrolled
9 charts
NCT00510627
2017-03-03
Prometheus
Boston Scientific Corporation
Phase 4
Withdrawn